Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells - PubMed (original) (raw)
. 1979 Jun 7;279(5713):523-5.
doi: 10.1038/279523a0.
- PMID: 571963
- DOI: 10.1038/279523a0
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells
P J Farrell et al. Nature. 1979.
No abstract available
Similar articles
- Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells.
Sen GC, Lebleu B, Brown GE, Rebello MA, Furuichi Y, Morgan M, Shatkin AJ, Lengyel P. Sen GC, et al. Biochem Biophys Res Commun. 1975 Jul 8;65(1):427-34. doi: 10.1016/s0006-291x(75)80111-2. Biochem Biophys Res Commun. 1975. PMID: 1147999 No abstract available. - Interferon enhances protein degradation in Ehrlich ascites-tumour cells [proceedings].
Panniers LR, Clemens MJ. Panniers LR, et al. Biochem Soc Trans. 1980 Jun;8(3):352-3. doi: 10.1042/bst0080352. Biochem Soc Trans. 1980. PMID: 6156868 No abstract available. - Release of the inhibition of messenger RNA translation in extracts of interferon-treated Ehrlich ascites tumor cells by added transfer RNA.
Gupta SL, Sopori ML, Lengyel P. Gupta SL, et al. Biochem Biophys Res Commun. 1974 Apr 8;57(3):763-70. doi: 10.1016/0006-291x(74)90612-3. Biochem Biophys Res Commun. 1974. PMID: 4363942 No abstract available. - Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s).
Gupta SL, Sopori ML, Lengyel P. Gupta SL, et al. Biochem Biophys Res Commun. 1973 Sep 18;54(2):777-83. doi: 10.1016/0006-291x(73)91491-5. Biochem Biophys Res Commun. 1973. PMID: 4356983 No abstract available. - A transfer RNA-dependent protein synthesizing system from Ehrlich ascites extracts.
Sharma OK, Roberts WK, Beezley DN, Borek E. Sharma OK, et al. Biochim Biophys Acta. 1975 May 16;390(3):327-31. doi: 10.1016/0005-2787(75)90353-6. Biochim Biophys Acta. 1975. PMID: 164951
Cited by
- Interferons and interferon-related pathways in heart disease.
Tran DT, Batchu SN, Advani A. Tran DT, et al. Front Cardiovasc Med. 2024 Apr 11;11:1357343. doi: 10.3389/fcvm.2024.1357343. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38665231 Free PMC article. Review. - Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage.
Homma H, Yoshioka Y, Fujita K, Shirai S, Hama Y, Komano H, Saito Y, Yabe I, Okano H, Sasaki H, Tanaka H, Okazawa H. Homma H, et al. Commun Biol. 2024 Apr 9;7(1):413. doi: 10.1038/s42003-024-06066-z. Commun Biol. 2024. PMID: 38594382 Free PMC article. - Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.
Husain M. Husain M. Pathogens. 2024 Jan 29;13(2):127. doi: 10.3390/pathogens13020127. Pathogens. 2024. PMID: 38392865 Free PMC article. Review. - Cellular targets and lysine selectivity of the HERC5 ISG15 ligase.
Zhao X, Perez JM, Faull PA, Chan C, Munting FW, Canadeo LA, Cenik C, Huibregtse JM. Zhao X, et al. iScience. 2024 Jan 9;27(2):108820. doi: 10.1016/j.isci.2024.108820. eCollection 2024 Feb 16. iScience. 2024. PMID: 38303729 Free PMC article. - Insights into the ISG15 transfer cascade by the UBE1L activating enzyme.
Wallace I, Baek K, Prabu JR, Vollrath R, von Gronau S, Schulman BA, Swatek KN. Wallace I, et al. Nat Commun. 2023 Dec 2;14(1):7970. doi: 10.1038/s41467-023-43711-3. Nat Commun. 2023. PMID: 38042859 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources